Genetic association of HLA-A*2601 with ocular Behçet's disease in Japanese patients

Clinical and Experimental Rheumatology

Volumn 28, Issue 4 SUPPL. 60, 2010, Pages

  Kaburaki, Toshikatsu ^a   Takamoto, Mitsuko ^a   Numaga, Jiro ^a   Kawashima, Hidetoshi ^a   Araie, Makoto ^a   Ohnogi, Yuka ^a   Harihara, Shinji ^b   Kuwata, Shoji ^c   Takeuchi, Fujio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; GENOMIC DNA; HLA A ANTIGEN; HLA B ANTIGEN; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; TACROLIMUS;

ADULT; ALLELE; ARTICLE; BEHCET DISEASE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETINITIS; UVEITIS; VISUAL ACUITY;

ADULT; ALLELES; BEHCET SYNDROME; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; UVEITIS;

EID: 78049382509     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. ZIERHUT M, MIZUKI N, OHNO S et al.: Immunology and functional genomics of Behçet's disease. Cell Mol Life Sci 2003; 60: 1903-22.
2. OHNO S, ASANUMA T, SUGIURA S, WAKISA-KA A, AIZAWA M, ITAKURA K: HLA-Bw51 and Behçet's disease. JAMA 1978; 240: 529.
3. MIZUKI N, INOKO H, ANDO H et al.: Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101. Am J Ophthalmol 1993; 116: 406-9.
4. MIZUKI N, OHNO S, ANDO H et al.: A strong association between HLA-B*5101 and Behçet's disease in Greek patients. Tissue Antigens 1997; 50: 57-60. (Pubitemid 27273714)
5. YABUKI K, OHNO S, MIZUKI N et al.: HLA class I and II typing of the patients with Behçet's disease in Saudi Arabia. Tissue Antigens 1999; 54: 273-7.
6. GONZALEZ-ESCRIBANO MF, RODRIGUEZ MR, WALTER K, SANCHEZ-ROMAN J, GARCIA-LOZANO JR, NUNEZ-ROLDAN A: Association of HLA-B51 subtypes and Behçet's disease in Spain. Tissue Antigens 1998; 52: 78-80.
7. PIRIM I, ATASOY M, IKBAL M, ERDEM T, ALIAGAOGLU C: HLA class I and class II genotyping in patients with Behçet's disease: a regional study of eastern part of Turkey. Tissue Antigens 2004; 64: 293-7.
8. MIZUKI N, OTA M, KIMURA M et al.: Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. Proc Natl Acad Sci USA 1997; 94: 1298-303.
9. MIZUKI N, OTA M, YABUKI K et al.: Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci 2000; 41: 3702-8.
10. MATSUKI K, JUJI T, TOKUNAGA K et al.: HLA antigens in Behçet's disease with refractory ocular attacks. Tissue Antigens 1987; 29: 208-13.
11. CHUNG YM, YEH TS, SHEU MM et al.: Behçet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc 1990; 89: 413-7.
12. ITOH Y, INOKO H, KULSKI JK et al.: Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behçet's disease by a PCR-SSOP-Luminex method. Tissue Antigens 2006; 67: 390-4.
13. INTERNATIONAL STUDY GROUP FOR BEHÇET'S DISEASE: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
14. ZIVADINOV R, UXA L, ZACCHI T et al.: HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis. J Neurol 2003; 250: 1099-106.
15. VREESE KD, BARYLSKI R, PUGHE F et al.: Performance Characteristics of Updated INNO-LiPA Assays for Molecular Typing of Human Leukocyte Antigen A (HLA-A), HLA-B, and HLA-DQB1 Alleles. Clin Diag Lab Immunol 2004, 11; 430-2.
16. BENEZRA D, COHEN E: Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol 1986; 70: 589-92.
17. TAKEUCHI M, HOKAMA H, TSUKAHARA R et al.: Risk and prognostic factors of poor visual outcome in Behçet's disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol 2005; 241: 1147-52.
18. YOSHIDA A, KAWASHIMA H, MOTOYAMA Y et al.: Comparison of patients with Behçet's disease in the 1980s and 1990s. Ophthalmology. 2004; 111: 810-5.
19. The allele frequencies of HLA-A alleles in donors of bone marrow transplantation in Japan (http://www.bmdc.jrc.or.jp/GF-A.htm. in Japanese)
20. The allele frequencies of HLA-B alleles in donors of bone marrow transplantation in Japan (http://www.bmdc.jrc.or.jp/GF-B.htm. in Japanese)
21. ARBER N, KLEIN T, MEINER Z, PRAS E, WEINBERGER A: Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome. Ann Rheum Dis 1991; 50: 351-3.
22. SOTO-VEGA E, GARCÍA-MUÑOZ R, RICHAUD-PATIN Y et al.: Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease. Immunol Lett 2004; 93: 211-5.
23. MISHIMA S, MASUDA K, IZAWA Y, MOCHIZUKI M, NAMBA K: The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc 1979; 77: 225-79.
24. DEMIROǦLU H, BARIŞTA I, DÜNDAR S: Risk factor assessment and prognosis of eye involvement in Behçet's disease in Turkey. Ophthalmology 1997; 104: 701-5.
25. SAKAMOTO M, AKAZAWA K, NISHIOKA Y, SANUI H, INOMATA H, NOSE Y: Prognostic factors of vision in patients with Behçet disease. Ophthalmology 1995; 102: 317-21.
26. KAÇMAZ RO, KEMPEN JH, NEWCOMB C et al.: Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group. Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol 2008; 146: 828-36.
27. KIM MS, KIM JH: Prognostic comparison of Behçet's disease with or without HLA-Bw 51 antigen. Korean J Ophthalmol 1989; 3: 85-9.
28. KILMARTIN DJ, FINCH A, ACHESON RW: Primary association of HLA-B51 with Behçet's disease in Ireland. Br J Ophthalmol 1997; 81: 649-53.